Summary
How MRK maps according to Revere
| Sector Level | Count |
|---|---|
Industries
|
2 |
Sectors
|
5 |
Subsectors
|
23 |
Product/Service Groups
|
287 |
Specific product example for MRK
| Product Hierarchy |
|---|
Consumer
|
Consumer Products and Services
|
Personal Care and Cleaning Products
|
Oral Care
|
Company Highlights:
Market Cap.
|
117,162.710 |
Current Shares Outstnd.
|
3,080.8 |
| Contact Name | Alex Kelly |
| Contact Phone | (908)4231000 |
| City, State | Whitehouse Station, NJ |
| Dividends Per Common Share | 0.42 |
| Dividend Yield | 4.42 |
IH % Shares Outst.
|
73.40% |
| Number of Employees | 91,000 |
| Revenue Per Employee | 518,484.3 |
| Book Value Per Share | 18.03 |
| 5 Year CAGR in Revenues % | 15.88 |
| 5 Year CAGR in Earnings % | -33.42 |
Asset Turnover
|
0.11 |
| Fiscal Year End | 12/31/2012 |
| Next Reporting Period | Jun, 2012 |
Business Description:
Chart:
| Last Price | 38.03 |
| Price Chg. | 0.00 |
| Price Chg. % | 0.00% |
| Open Price | 38.20 |
| High Price | 38.34 |
| Low Price | 37.95 |
| 52w High Price | 39.50 |
| 52w Low Price | 29.47 |
| Volume | 12,111,387 |
| 30d Avg. Volume | 12,436,186 |
Products
| Products Manufactured/Services Performed Details |
|---|
Consumer
|
Consumer Products and Services
|
Personal Care and Cleaning Products
|
Oral Care
Products:
|
Skin Care
Products:
|
Healthcare
|
Biopharmaceuticals
|
Allergies
|
Dermatology
|
Antihistamines
Products:
|
Ophthalmology
|
Antihistamines/Mast Cell Stabilizers
Products:
|
Phase I/Phase II Clinical Stage Products
Products:
|
Upper Respiratory
|
Antihistamines
Products:
|
Antihistamines/Analgesics/Antipyretics
Products:
|
Antihistamines/Antitussives
Products:
|
Antihistamines/Decongestants
Products:
|
Antihistamines/Decongestants/Analgesics/Antipyretics
Products:
|
Antihistamines/Leukotriene Receptor Antagonists
Products:
|
Leukotriene Receptor Antagonists
Products:
|
Steroidal Anti-Inflammatory Drugs (SAID)
Products:
|
Vaccine Adjuvants
Products:
|
Cardiovascular System
|
Heart Disorders
|
Acute Coronary Syndrome (ACS)
|
Anticoagulating Agents
|
Platelet Aggregation Inhibitors
|
Glycoprotein IIb/IIIa Receptor Blocking Agents
Products:
|
Thrombin Inhibitors
Products:
|
Cholesterol Absorption Inhibitors (CETP)/HMG CoA Reductase Inhibitors (Statins)
Products:
|
Angina
|
Anticoagulating Agents
|
Platelet Aggregation Inhibitors
|
Glycoprotein IIb/IIIa Receptor Blocking Agents
Products:
|
Vasodilatory Agents
Products:
|
Arrhythmia
|
Sodium Channel Blocking Agents/Potassium Channel Blocking Agents
Products:
|
Heart Failure (HF)
|
Adjunctive Treatments
|
Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors)
Products:
|
Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors)
Products:
|
Complications
|
Edema
|
Loop Diuretic Agents
Products:
|
Thiazide Diuretic Agents
Products:
|
Myocardial Infarction (MI)
|
Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors)
Products:
|
Anticoagulating Agents
|
Platelet Aggregation Inhibitors
|
Glycoprotein IIb/IIIa Receptor Blocking Agents
Products:
|
Thrombin Inhibitors
Products:
|
Phase I/Phase II Clinical Stage Products
Products:
|
Research/Preclinical Stage Products
Products:
|
Vascular Disorders
|
Atherosclerosis
|
Free Fatty Acid Inhibitors/Prostaglandin Inhibitors
Products:
|
Free Fatty Acid Inhibitors/Prostaglandin Inhibitors/Statins
Products:
|
HMG CoA Reductase Inhibitors (Statins)
Products:
|
Coronary Artery Disease (CAD)
|
HMG CoA Reductase Inhibitors (Statins)
Products:
|
Hypertension
|
Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors)
Products:
|
Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors)/Thiazide Diuretic Agents
Products:
|
Angiotensin II Receptor Antagonists
Products:
|
Angiotensin II Receptor Antagonists/Thiazide Diuretic Agents
Products:
|
Vasodilatory Agents
Products:
|
Stroke
|
Angiotensin II Receptor Antagonists
Products:
|
Angiotensin II Receptor Antagonists/Thiazide Diuretic Agents
Products:
|
Anticoagulating Agents (Anticoagulants)
|
Thrombin Inhibitors
Products:
|
Dermatology
|
Hair Disorders
|
Alopecia (Hair Loss)
|
5 Alpha Reductase Inhibitors
Products:
|
Lesion/Scaling Disorders
|
Dermatoses
|
Steroidal Anti-Inflammatory Drugs (SAID)
Products:
|
Diaper Rash
|
Zinc Oxide
Products:
|
Pemphigus Vulgaris
|
Steroidal Anti-Inflammatory Drugs (SAID)
Products:
|
Psoriasis
|
Tumor Necrosis Factor-Alpha Antagonists (TNF-Alpha Antagonists)
Products:
|
Phase I/Phase II Clinical Stage Products
Products:
|
Research/Preclinical Stage Products
Products:
|
Digestive System
|
Gastrointestinal Tract Disorders
|
Gastroduodenal Disorders
|
Peptic Ulcers
|
Duodenal
|
H2 Receptor Antagonists
Products:
|
Gastric
|
H2 Receptor Antagonists
Products:
|
Zollinger-Ellison Syndrome
|
H2 Receptor Antagonists
Products:
|
Gastroesophageal Disorders
|
Abdominal Gas
|
Gas Bubble Surface Tension Reducing Agents
Products:
|
Acid Indigestion/Heartburn
|
Acid Neutralizing Agents
Products:
|
Acid Neutralizing Agents/H2 Receptor Antagonists
Products:
|
H2 Receptor Antagonists
Products:
|
Proton Pump Inhibitors
Products:
|
Gastroesophageal Reflux Disease (GERD)
|
H2 Receptor Antagonists
Products:
|
Nausea/Vomiting
|
Neurokinin-1 (NK-1) Receptor Antagonists
Products:
|
Intestinal Disorders
|
Constipation
|
Chronic
|
Stool Softeners/Stimulants
Products:
|
Impacted Bowels
|
Stool Softeners
Products:
|
Inflammatory Bowel Disease (IBD)
|
Crohn`s Disease
|
Tumor Necrosis Factor-Alpha Antagonists (TNF-Alpha Antagonists)
Products:
|
Ulcerative Colitis
|
Tumor Necrosis Factor-Alpha Antagonists (TNF-Alpha Antagonists)
Products:
|
Liver Disorders
|
Cirrhosis
|
Complications
|
Edema
|
Loop Diuretic Agents
Products:
|
Thiazide Diuretic Agents
Products:
|
Hepatitis
|
Hepatitis B
|
Chronic
|
Interferons
Products:
|
Hepatitis C
|
Chronic
|
Interferons
Products:
|
Interferons/Nucleoside Analogs
Products:
|
Nucleoside/Nucleotide Analogs
Products:
|
Protease Inhibitors
Products:
|
Wilson`s Disease
|
Chelating Agents
Products:
|
Phase I/Phase II Clinical Stage Products
Products:
|
Endocrinology/Metabolism
|
Diabetes
|
Induced Complications
|
Diabetic Foot Ulcers
|
Carbapenems
Products:
|
Diabetic Nephropathy
|
Angiotensin II Receptor Antagonists
Products:
|
Non-Insulin Dependent Diabetes Mellitus (NIDDM)/Type 2 Diabetes
|
Biguanides/Dipeptidyl Peptidase (DPP) Inhibitors
Products:
|
Dipeptidyl Peptidase (DPP) Inhibitors
Products:
|
Dipeptidyl Peptidase (DPP) Inhibitors/HMG CoA Reductase Inhibitors (Statins)
Products:
|
Dipeptidyl Peptidase (DPP) Inhibitors/PPAR Agonists
Products:
|
General Hormone Treatments
|
Betamethasones
Products:
|
Intermediary Metabolism Disorders
|
Gout
|
Gouty Arthritis
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID)
|
Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors)
Products:
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Products:
|
Hypercholesterolemia
|
Cholesterol Absorption Inhibitors
Products:
|
Cholesterol Absorption Inhibitors/HMG CoA Reductase Inhibitors (Statins)
Products:
|
HMG CoA Reductase Inhibitors (Statins)
Products:
|
Hyperlipidemia
|
Cholesterol Absorption Inhibitors
Products:
|
HMG CoA Reductase Inhibitors (Statins)
Products:
|
Phase I/Phase II Clinical Stage Products
Products:
|
Reproductive Disorders
|
Hypogonadism
|
Male
|
Gonadotropins
Products:
|
Menopause
|
Selective Estrogen Receptor Modulators (SERM)
Products:
|
Serotonin Receptor Antagonists
Products:
|
Research/Preclinical Stage Products
Products:
|
Hematology
|
Phase I/Phase II Clinical Stage Products
Products:
|
Research/Preclinical Stage Products
Products:
|
Serum Factor Disorders
|
Hypercholesterolemia
|
Cholesterol Absorption Inhibitors
Products:
|
Cholesterol Absorption Inhibitors/HMG CoA Reductase Inhibitors (Statins)
Products:
|
Cholesteryl Ester Transfer Protein Inhibitors (CETP)
Products:
|
HMG CoA Reductase Inhibitors (Statins)
Products:
|
Hyperlipidemia
|
Cholesterol Absorption Inhibitors
Products:
|
HMG CoA Reductase Inhibitors (Statins)
Products:
|
Hypokalemia
|
Potassium Supplements
Products:
|
Thrombocyte (Platelet) Disorders
|
Hypoprothrombinemia
|
Vitamin K Analogs
Products:
|
White Blood Cell (WBC) Disorders
|
Myelodysplastic Syndromes (MDS)
|
Farnesyl Transferase Inhibitors
Products:
|
Immunology
|
Autoimmune Disorders
|
Arthritis
|
Psoriatic Arthritis
|
Monoclonal Antibodies
Products:
|
Tumor Necrosis Factor-Alpha Antagonists (TNF-Alpha Antagonists)
Products:
|
Rheumatoid Arthritis (RA)
|
Analgesics
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID)
|
Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors)
Products:
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Products:
|
Immunotherapy
|
Chelating Agents
Products:
|
Monoclonal Antibodies
Products:
|
Tumor Necrosis Factor-Alpha Antagonists (TNF-Alpha Antagonists)
Products:
|
Inflammatory Bowel Disease (IBD)
|
Crohn`s Disease
|
Tumor Necrosis Factor-Alpha Antagonists (TNF-Alpha Antagonists)
Products:
|
Ulcerative Colitis
|
Tumor Necrosis Factor-Alpha Antagonists (TNF-Alpha Antagonists)
Products:
|
Psoriasis
|
Tumor Necrosis Factor-Alpha Antagonists (TNF-Alpha Antagonists)
Products:
|
Immune Deficiency Disorders
|
Human Immunodeficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS)
|
Integrase Inhibitors
Products:
|
Protease Inhibitors
Products:
|
Phase I/Phase II Clinical Stage Products
Products:
|
Research/Preclinical Stage Products
Products:
|
Infectious Diseases
|
Bacterial
|
Antibacterial Agents
|
Broad Spectrum
|
Antibiotics
|
Carbapenems
Products:
|
Lipopeptides
Products:
|
Quinolones/Fluoroquinolones
Products:
|
Narrow Spectrum
|
Ophthalmology
|
Conjunctivitis
|
Macrolides
Products:
|
Respiratory System
|
Pneumonia
|
Quinolones/Fluoroquinolones
Products:
|
Respiratory Tract Infections
|
Quinolones/Fluoroquinolones
Products:
|
Urology
|
Prostatitis
|
Quinolones/Fluoroquinolones
Products:
|
Urinary Tract Infections (UTI)
|
Antibacterial Agents (Antibiotics)
|
Quinolones/Fluoroquinolones
Products:
|
Vaccines
|
Bacterial
|
Single Target
|
Haemophilus Influenzae Type B (Hib)
Products:
|
Streptococcus pneumoniae
Products:
|
Bacterial/Viral
Products:
|
Helminthic
|
Onchocerciasis (River Blindness)
|
Gamma-Aminobutyric Acid (GABA) Agonists
Products:
|
Strongyloidiasis (Threadworm)
|
Gamma-Aminobutyric Acid (GABA) Agonists
Products:
|
Mycological (Fungal)
|
Antifungal Agents
|
Broad Spectrum
|
Azoles
|
Imidazoles
Products:
|
Echinocandins
Products:
|
Narrow Spectrum
|
Dermatology
|
Tinea Corporis (Ringworm)
|
Azoles
|
Imidazoles
Products:
|
Imidazoles/Steroidal Anti-Inflammatory Drugs (SAID)
Products:
|
Thiocarbamates
Products:
|
Tinea Cruris (Jock Itch)
|
Azoles
|
Imidazoles
Products:
|
Imidazoles/Steroidal Anti-Inflammatory Drugs (SAID)
Products:
|
Thiocarbamates
Products:
|
Tinea Pedis
|
Azoles
|
Imidazoles
Products:
|
Imidazoles/Steroidal Anti-Inflammatory Drugs (SAID)
Products:
|
Thiocarbamates
Products:
|
Digestive System
|
Mucous
|
Candidiasis
|
Echinocandins
Products:
|
Urology
|
Vaginal Candidiasis
|
Azoles
|
Imidazoles
Products:
|
Phase I/Phase II Clinical Stage Products
Products:
|
Viral
|
DNA Viruses
|
Hepadnavirus
|
Hepatitis B
|
Chronic
|
Interferons
Products:
|
Papillomavirus
|
Verrucae (Warts)
|
Interferons
Products:
|
RNA Viruses
|
Flavivirus
|
Hepatitis C
|
Chronic
|
Interferons
Products:
|
Interferons/Nucleoside Analogs
Products:
|
Nucleoside/Nucleotide Analogs
Products:
|
Protease Inhibitors
Products:
|
Retrovirus
|
Human Immunodeficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS)
|
Integrase inhibitors
Products:
|
Protease Inhibitors
Products:
|
Vaccines
|
Bacterial/Viral
Products:
|
Viral
|
Combination
|
Measles/Mumps/Rubella
Products:
|
Measles/Mumps/Rubella/Varicella
Products:
|
Measles/Rubella
Products:
|
Single Target
|
Hepatitis A
Products:
|
Hepatitis B
Products:
|
Herpes Zoster (Shingles)
Products:
|
Influenza (Flu)
Products:
|
Measles
Products:
|
Mumps
Products:
|
Papillomavirus
Products:
|
Rotavirus
Products:
|
Rubella (German Measles)
Products:
|
Varicella-Zoster Virus (Chicken Pox)
Products:
|
Musculoskeletal System
|
Phase I/Phase II Clinical Stage Products
Products:
|
Skeletal Disorders
|
Bone Disorders
|
Osteoporosis
|
Cathepsin K Inhibitors
Products:
|
Osteoclast Bone Resorption Inhibitors
Products:
|
Osteoclast Bone Resorption Inhibitors/Vitamin D Analogs
Products:
|
Selective Estrogen Receptor Modulators (SERM)
Products:
|
Paget`s Disease
|
Osteoclast Bone Resorption Inhibitors
Products:
|
Joint Disorders
|
Ankylosing Spondylitis
|
Immunotherapy
|
Monoclonal Antibodies
Products:
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID)
|
Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors)
Products:
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Products:
|
Tumor Necrosis Factor-Alpha Antagonists (TNF-Alpha Antagonists)
Products:
|
Gouty Arthritis
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID)
|
Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors)
Products:
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Products:
|
Osteoarthritis (OA)
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID)
|
Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
Products:
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Products:
|
Psoriatic Arthritis
|
Monoclonal Antibodies
Products:
|
Tumor Necrosis Factor-Alpha Antagonists (TNF-Alpha Antagonists)
Products:
|
Rheumatoid Arthritis (RA)
|
Analgesics
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID)
|
Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
Products:
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Products:
|
Immunotherapy
|
Chelating Agents
Products:
|
Monoclonal Antibodies
Products:
|
Tumor Necrosis Factor-Alpha Antagonists (TNF-Alpha Antagonists)
Products:
|
Neurology
|
Neurological Disorders
|
Headaches
|
Vascular (Migraine)
|
Acute Treatments
|
CGRP Receptor Antagonists
Products:
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID)
|
Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
Products:
|
Selective Serotonin Receptor Agonists (Triptans)
Products:
|
Phase I/Phase II Clinical Stage Products
Products:
|
Psychiatric Disorders
|
Mood Disorders
|
Bipolar Disorders (Manic Depressive Disorders)
|
Serotonin/Dopamine Receptor Blocking Agents
Products:
|
Depression
|
Tetracyclic Compounds
Products:
|
Tricyclic Compounds
Products:
|
Schizophrenia
|
Serotonin/Dopamine Receptor Blocking Agents
Products:
|
Sleep Disorders
|
Insomnia
|
Orexin Receptor Antagonists
Products:
|
Serotonin Receptor Antagonists
Products:
|
Research/Preclinical Stage Products
Products:
|
Obstetrics/Gynecology
|
Child Birth/Pregnancy
|
Prevention (Contraception)
|
Contraceptives (Birth Control)
|
Estrogens
Products:
|
Estrogens/Progestins
Products:
|
Progestins
Products:
|
Female Genital Disorders
|
Infertility
|
Hormonal Treatments
|
Gonadotropins
Products:
|
Ovulation Stimulating Agents
Products:
|
Phase I/Phase II Clinical Stage Products
Products:
|
Oncology
|
Dermatology
|
Kaposi`s Sarcoma
|
Interferons
Products:
|
Malignant Melanoma
|
Interferons
Products:
|
Digestive System
|
Anal Cancer
|
Papillomavirus Vaccines
Products:
|
Endocrinology
|
Adrenal Glands
|
Pheochromocytoma
|
Tyrosine Hydroxylase Inhibitors
Products:
|
Hematology
|
Leukemia (White Blood Cell Cancer)
|
Lymphoid
|
Acute
|
Lymphocytic
|
Asparaginases
Products:
|
Chronic
|
Hairy Cell
|
Interferons
Products:
|
Myeloid
|
Chronic
|
Myelogenous (CML)
|
Interferons
Products:
|
Palliative Agents
|
Alkylating Agents
|
Nitrogen Mustard Type
Products:
|
Lymphoma (Lymphatic Cancer)
|
Cutaneous T-Cell Lymphoma (CTCL)
|
Alkylating Agents
|
Nitrogen Mustard Type
Products:
|
Histone Deacetylase (HDAC) Inhibitors
Products:
|
Hodgkin`s Disease
|
Palliative Agents
|
Alkylating Agents
|
Nitrogen Mustard Type
Products:
|
Non-Hodgkin`s Lymphoma (NHL)
|
Interferons
Products:
|
Multiple Myeloma (Plasma Cell Cancer)
|
Topoisomerase II Inhibitors
Products:
|
Musculoskeletal System
|
Bone Cancer
|
Ewing`s Sarcoma (Primitive Neuroepithelial Cancer)
|
Antitumor Antibiotics
Products:
|
Metastatic
|
Mammalian Target Of Rapamycin (mTOR) Inhibitors
Products:
|
Rhabdomyosarcoma
|
Antitumor Antibiotics
Products:
|
Neurology
|
Brain Cancer
|
Glioma
|
Astrocytoma
|
Alkylating Agents
|
Imidazotetrazines
Products:
|
Glioblastoma
|
Alkylating Agents
|
Imidazotetrazines
Products:
|
Phase I/Phase II Clinical Stage Products
Products:
|
Urology
|
Cervical Cancer
|
Localized
|
Papillomavirus Vaccines
Products:
|
Kidney Cancer (Renal Cell Carcinoma)
|
Wilm`s Tumor (Nephroblastoma)
|
Antitumor Antibiotics
Products:
|
Ovarian Cancer
|
Adenocarcinoma
|
Small Molecule Drug Conjugates (SMDC)
Products:
|
Testicular Cancer
|
Metastatic
|
Antitumor Antibiotics
Products:
|
Urinary Bladder Cancer
|
Papillocarcinoma
|
Vaccines
Products:
|
Uterine Cancer
|
Antitumor Antibiotics
Products:
|
Vulvar Cancer
|
Squamous Cell Carcinoma
|
Papillomavirus Vaccines
Products:
|
Ophthalmology
|
Degenerative Disorders
|
Dry Eye
|
Immunosuppressants
Products:
|
Lubricants
Products:
|
Glaucoma
|
Carbonic Anhydrase Inhibitors
Products:
|
Carbonic Anhydrase Inhibitors/Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Products:
|
Prostanoid Selective FP Receptor Agonists
Products:
|
Irritation/Inflammation
|
Vasoconstricting Agents
Products:
|
Non-Degenerative Disorders
|
Allergic Conjunctivitis
|
Antihistamines/Mast Cell Stabilizers
Products:
|
Phase I/Phase II Clinical Stage Products
Products:
|
Pain Management
|
Anesthesia
|
General (Systemic)
|
Adjunctive
|
Acetylcholine Blocking Agents
Products:
|
Reversal
|
Selective Relaxant Binding Agents
Products:
|
Non-Narcotics
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID)
|
Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
Products:
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Products:
|
Skeletal Muscle Relaxing Agents
Products:
|
Phase I/Phase II Clinical Stage Products
Products:
|
Respiratory System
|
Lower Respiratory Tract Disorders (Lung Disorders)
|
Asthma
|
Acute Treatments
|
Bronchodilators
|
Beta Adrenergic Receptor Agonists
Products:
|
Prophylactic Treatments
|
Beta Adrenergic Receptor Agonists/Steroidal Anti-Inflammatory Drugs (SAID)
Products:
|
Leukotriene Receptor Antagonists
Products:
|
Steroidal Anti-Inflammatory Drugs (SAID)
Products:
|
Bronchitis
|
Acute Treatments
|
Bronchodilators
|
Beta Adrenergic Receptor Agonists
Products:
|
Bronchospasm
|
Bronchodilators
|
Beta Adrenergic Receptor Agonists
Products:
|
Chronic Obstructive Pulmonary Disease (COPD)
|
Acute Treatments
|
Bronchodilators
|
Beta Adrenergic Receptor Agonists
Products:
|
Prophylactic Treatments
|
Beta Adrenergic Receptor Agonists/Steroidal Anti-Inflammatory Drugs (SAID)
Products:
|
Cystic Fibrosis (CF)
|
P2Y2 Agonists
Products:
|
Phase I/Phase II Clinical Stage Products
Products:
|
Research/Preclinical Stage Products
Products:
|
Upper Respiratory Tract Disorders
|
Coughs/Colds
|
Antihistamines
Products:
|
Antihistamines/Analgesics/Antipyretics
Products:
|
Antihistamines/Antitussives
Products:
|
Antihistamines/Antitussives/Analgesics/Antipyretics
Products:
|
Antihistamines/Decongestants
Products:
|
Antihistamines/Decongestants/Analgesics/Antipyretics
Products:
|
Antitussives
Products:
|
Antitussives/Expectorants
Products:
|
Decongestants
Products:
|
Steroidal Anti-Inflammatory Drugs (SAID)
Products:
|
Nasal Polyposis
|
Steroidal Anti-Inflammatory Drugs (SAID)
Products:
|
Surgery
|
Cardiovascular System
|
Complications
|
Ischemia
|
Adenosine Regulating Agents (ARA)
Products:
|
Anticoagulating Agents (Anticoagulants)
|
Platelet Aggregation Inhibitors
|
Glycoprotein IIb/IIIa Receptor Blocking Agents
Products:
|
Oncology
|
Endocrinology
|
Adrenal Glands
|
Tyrosine Hydroxylase Inhibitors
Products:
|
Toxicology
|
Substance Abuse
|
Withdrawal
|
Narcotics
|
Opioid Analgesics
Products:
|
Urology
|
Male Genital Disorders
|
Penile
|
Erectile Dysfunction (Impotence)
|
Phosphodiesterase Type 5 Inhibitors (PDE-5 Inhibitors)
Products:
|
Prostate
|
Benign Prostate Hyperplasia (BPH)
|
5-Alpha Reductase Inhibitors
Products:
|
Testicular
|
Cryptorchidism
|
Gonadotropins
Products:
|
Hypogonadism
|
Gonadotropins
Products:
|
Phase I/Phase II Clinical Stage Products
Products:
|
Urological Disorders
|
Bladder
|
Neurogenic Bladder Disease
|
Cholinergic Agents
Products:
|
Kidney (Renal)
|
Chronic Renal Failure (CRF)
|
Complications
|
Cardiovascular
|
Cholesterol Absorption Inhibitors
Products:
|
Cholesterol Absorption Inhibitors/HMG CoA Reductase Inhibitors (Statins)
Products:
|
Edema
|
Loop Diuretic Agents
Products:
|
Thiazide Diuretic Agents
Products:
|
Cystinuria
|
Chelating Agents
Products:
|
Diabetic Nephropathy
|
Angiotensin II Receptor Antagonists
Products:
|
Weight Management
|
Phase I/Phase II Clinical Stage Products
Products:
|
Medical Devices
|
Obstetrics/Gynecology
|
Treatment
|
Procedure Specific
|
Contraception
|
Implants
Products:
|
Outsourced Biomedical Services
|
Development/Manufacturing Services
|
Contract Manufacturing Organizations (CMO)
|
Biopharmaceutical OEM
|
Biologics
Products:
|
Veterinary Products and Services
|
Veterinary Pharmaceuticals
Products:
|
Key Financials
| Period Length/End |
3 months ending 03/31/2012 |
3 months ending 12/31/2011 |
3 months ending 03/31/2011 |
12 months ending 12/31/2011 |
12 months ending 12/31/2010 |
12 months ending 12/31/2009 |
| Total Revenue | 11,731.0 | 12,294.0 | 11,580.0 | 48,047.0 | 45,987.0 | 27,428.0 |
Gross Margin %
|
65.59 | 66.03 | 64.95 | 64.89 | 60 | 67.12 |
Operating Income
|
2,507.0 | 1,580.0 | 1,729.0 | 7,334.0 | 1,653.0 | 15,290.0 |
Operating Margin %
|
21.37 | 12.85 | 14.93 | 15.26 | 3.59 | 55.75 |
| Tax Rate % | 29.52 | 2.34 | 38.06 | 12.84 | 40.59 | 14.83 |
| Income After Taxes | 1,767.0 | 1,543.0 | 1,071.0 | 6,392.0 | 982.0 | 13,022.0 |
| Net Income Margin % | 15.06 | 12.55 | 9.25 | 13.3 | 2.14 | 47.48 |
F.D. EPS - Incl. Xord. Items
|
0.56 | 0.49 | 0.34 | 2.02 | 0.28 | 5.65 |
| Book Value Per Share | 18.03 | 17.93 | 17.63 | 17.93 | 17.64 | 19.00 |
Ratios
P/R Ratio (TTM)
|
2.43 |
P/E Ratio (TTM)
|
16.89 |
| Price To Free Cash Flow (TTM) | n/a |
| Price To Book Value | 2.11 |
| Net Assets to Market Cap. % | 51.51% |
| Beta | 0.71 |
Days to Sell Inventory
|
142.89 |
Current Ratio
|
2.07 |
Quick Ratio
|
1.46 |
| Interest Coverage | n/a |
| Debt to Market Cap. % | 13.00% |
| Return on Equity % | 51.68 |
| Return on Assets % | 26.87 |
| Return on Invested Capital % | 38.83 |
Major Competitors
| Name | Trailing Revenue | P/R Ratio (TTM) | P/E Ratio (TTM) | 1 Year Return % | Overlap |
|---|---|---|---|---|---|
| Average |
Notes:
- The Company?s competitors include other worldwide research-based pharmaceutical companies, smaller research companies with more limited therapeutic focus, and generic drug and consumer health care manufacturers. The Company did not disclose any competitors for the fiscal year ended December 31, 2011.
Customers
| Name | Last Quarter Financial Stats | 1 YR Price Performance % | |||
|---|---|---|---|---|---|
| Y/Y Revenue Growth % | Sequential Revenue Growth % | Y/Y Margin Growth % | Sequential Margin Growth % | ||
Alliance HealthCare Services Inc
|
2.51 | -4.84 | 54.51 | 85.31 | -70.11% |
AmerisourceBergen Corp
|
1.57 | -1.42 | -0.78 | 31.07 | -13.24% |
Cardinal Health Inc
|
3.25 | -0.59 | 14.02 | 17.90 | -5.30% |
McKesson Corp
|
9.86 | 2.79 | 4,365.08 | -0.11 | 6.18% |
Sanofi
|
8.26 | -2.71 | 169.67 | -58.47 | -5.80% |
The Zuellig Group, Inc.
|
n/a | n/a | n/a | n/a | n/a |
| Average | 5.09 | -1.36 | 920.50 | 15.14 | -17.65% |
Notes:
- Merck sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations, pharmacy benefit managers and other institutions. The company?s four largest customers, Cardinal Health, Inc., AmerisourceBergen Corporation, McKesson Corporation, Alliance Healthcare, and Zuellig Pharma Ltd., represented, in aggregate, approximately one-fourth of accounts receivable at December 31, 2011. The company does not disclose revenues derived from any specific customer for the fiscal period.
Strategic Partners
| Name | Partnership Types | 1 YR Price Performance % |
|---|---|---|
ALK-Abelló A/S
|
Research Collaboration | n/a |
Ariad Pharmaceuticals Inc
|
In-licensing, Research Collaboration, Supplier | 87.72% |
Astrazeneca PLC
|
In-licensing, Joint Venture, Supplier | -16.27% |
BILL & MELINDA GATES FOUNDATION TRUST
|
Research Collaboration | n/a |
Cristália Produtos Químicos Farmacêuticos Ltda.
|
Distribution, Joint Venture, Marketing | n/a |
Cubist Pharmaceuticals Inc
|
In-licensing, Supplier | 21.65% |
Endocyte Inc
|
In-licensing, Supplier | -41.04% |
Eurofarma Laboratórios Ltda.
|
Distribution, Joint Venture, Marketing | n/a |
Government - Botswana
|
Research Collaboration | n/a |
Hanwha Chemical Corp
|
In-licensing, Research Collaboration | n/a |
Johnson & Johnson
|
In-licensing, Supplier | -3.35% |
Parexel International Corp
|
In-licensing, Supplier | 5.95% |
Portola Pharmaceuticals, Inc.
|
Research Collaboration | n/a |
Roche Holding AG
|
Marketing | 1.15% |
Sanofi
|
Research Collaboration | -5.80% |
Serum Institute of India, Ltd.
|
Research Collaboration | n/a |
Simcere Pharmaceutical Group
|
Joint Venture | -24.28% |
Sun Pharmaceutical Industries Ltd
|
Joint Venture | n/a |
United Parcel Service Inc
|
Distribution | 2.38% |
Alliance HealthCare Services Inc